Blank Bio · Jul 2026
Blank Bio introduced Ladon, its bulk transcriptomics foundation model, and described its embedding-search MCP for scientific discovery.
RNA-based AI for better drugs and smarter clinical trials.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Blank Bio is a San Francisco-based YC S25 applied AI research lab building RNA foundation models for precision oncology and clinical-trial decision support. It was founded in 2025, raised a $7.2M seed round in May 2026, and is collaborating with PacBio on long-read RNA-seq data to improve patient-level prediction.
Primary product
RNA foundation models for precision oncology and clinical-trial decision support (including its bulk transcriptomics model Ladon)
Founded
2025
Headquarters
San Francisco, California, United States
Team size
2-10 employees
Industry
Biotechnology Research
Sub-industry
RNA foundation models / precision oncology AI
Offices
0 jobs at Blank Bio
Check back later for new openings
Business model
Stage
Seed
Total raised
$7.2M
Latest round
Seed · May 2026
Latest amount
$7.2M
May 2026
Early-stage, fast-moving, cross-disciplinary, and comfortable with ambiguity; the team emphasizes ownership and helping shape both the science and the culture.
Visa sponsorship
Yes
Compensation
Public job postings show salaries of roughly $125K-$250K depending on role, plus 0.20%-1.00% early-stage equity.
Benefits
Pricing
Custom enterprise / research-partnership pricing; not publicly disclosed.
Differentiators
Technology
Customers
Competitors
Blank Bio · Jul 2026
Blank Bio introduced Ladon, its bulk transcriptomics foundation model, and described its embedding-search MCP for scientific discovery.
Business Wire · May 2026
Blank Bio announced a $7.2M seed round and a strategic collaboration with PacBio to generate long-read RNA-seq data for model training and evaluation.
GenomeWeb · May 2026
GenomeWeb covered the seed round, investors, and the PacBio collaboration, including the company’s use of public and proprietary RNA-seq data.
BioSpace · May 2026
BioSpace republished the press release describing the seed financing, founders, and collaboration details.